Zobrazeno 1 - 10
of 30
pro vyhledávání: '"David T. Wyatt"'
Publikováno v:
Hormone Research in Paediatrics. 90:266-269
Background: Variance between current American Diabetes Association (ADA) and International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines and in clinical practice exists for the use of thyroid antibody and thyroid function screening
Publikováno v:
International Journal of Pediatric Endocrinology, Vol 2010 (2010)
International Journal of Pediatric Endocrinology, Vol 2010, Iss 1, p 652013 (2010)
International Journal of Pediatric Endocrinology
International Journal of Pediatric Endocrinology, Vol 2010, Iss 1, p 652013 (2010)
International Journal of Pediatric Endocrinology
Objective. To characterize the pediatric endocrinologists' evaluation and followup of short-statured patients. Study Design. Observational study of 21,548 short-statured children (April 1996 to December 1999). Baseline demographics, laboratory testin
Autor:
David T. Wyatt
Publikováno v:
European Journal of Endocrinology. :S55-S59
OBJECTIVE: To review the National Cooperative Growth Study (NCGS), a national post-marketing surveillance program for children treated with biosynthetic growth hormone (GH) products from Genentech. METHODS: Representative data are presented to summar
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition. 33:462-465
Background The relationship between celiac disease and juvenile diabetes has long been known. Only a single study in the United States, from Buffalo, New York, has reported the prevalence of celiac disease in a pediatric diabetic population. This stu
Autor:
Peter Van Tuinen, Raymond G. Hoffmann, Arnold H. Slyper, S. Richton, David T. Wyatt, Jeffrey D Shadley
Publikováno v:
Pediatric Research. 47:634-639
Increased chromosomal rearrangements and chromosomal fragility have been previously observed in lymphocytes of children treated with human GH, implying that treatment could predispose to malignancy. Twenty-four children with classic GH deficiency, ne
Autor:
David T. Wyatt
Publikováno v:
Pediatrics. 104:1045-1050
There is concern that growth hormone (GH) therapy may influence the growth of melanocytic nevi. In a review of the experience of the National Cooperative Growth Study, we found no excess of skin cancer in children who were treated with GH. We also re
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:3493-3497
The occurrence of central hypothyroidism in previously euthyroid children during GH therapy has been reported with widely varying incidence. We monitored the acute effects on the hypothalamic-pituitary-thyroid axis in 15 euthyroid children with class
Autor:
Dorothy I. Shulman, Alicia C. Shillington, Bradley S. Miller, Michael S. Kappy, Darrell M. Wilson, David L Schwartz, Qing Harshaw, Bert Bakker, David T. Wyatt
Publikováno v:
International Journal of Pediatric Endocrinology
International Journal of Pediatric Endocrinology, Vol 2010 (2010)
International Journal of Pediatric Endocrinology, Vol 2010, Iss 1, p 891571 (2010)
International Journal of Pediatric Endocrinology, Vol 2010 (2010)
International Journal of Pediatric Endocrinology, Vol 2010, Iss 1, p 891571 (2010)
Our purpose was to determine pediatric endocrinologists' knowledge, attitudes, beliefs, and practices (KABPs) regarding recombinant human growth hormone (rhGH) treatment, examine care-related attitude consensus or discordance, and identify evidence-b
Autor:
Ilona J. Frieden, Kristen E. Holland, Anthony J. Mancini, David T. Wyatt, Beth A. Drolet, Peter C. Frommelt
Publikováno v:
Archives of Dermatology. 146
Background Propranolol hydrochloride has been prescribed for decades in the pediatric population for a variety of disorders, but its effectiveness in the treatment of infantile hemangiomas (IHs) was only recently discovered. Since then, the use of pr
Publikováno v:
Pediatrics. 115(5)
Background and Objectives. Insulin replacement regimens now stress the importance of administering throughout the day insulin doses that are based on flexible food choices and focusing on improved metabolic control. A flexible multiple daily insulin